Victory Capital Management Inc Regenxbio Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$18.08 - $24.55 $122,094 - $165,786	-6,753 Reduced 38.54%	10,768 $203,000
Q4 2022 Feb 10, 2023	BUY	$20.4 - $24.73 $60,955 - $73,893	2,988 Added 20.56%	17,521 $397,000
Q4 2022 Feb 09, 2023	SELL	$20.4 - $24.73 $371,667 - $450,555	-18,219 Reduced 55.63%	14,533 $329,000
Q3 2022 Nov 02, 2022	BUY	$22.29 - $35.04 $190,267 - $299,101	8,536 Added 35.25%	32,752 $866,000
Q2 2022 Aug 01, 2022	BUY	$19.35 - $35.04 $193,345 - $350,119	9,992 Added 70.25%	24,216 $598,000
Q1 2022 May 04, 2022	BUY	$24.62 - $34.31 $350,194 - $488,025	14,224 New	14,224 $395,000
Q4 2021 Feb 07, 2022	SELL	$30.19 - $40.28 $144,730 - $193,102	-4,794 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$29.09 - $45.68 $139,457 - $218,989	4,794 New	4,794 $201,000
Q2 2020 Aug 07, 2020	SELL	$27.75 - $43.44 $130,314 - $203,994	-4,696 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$21.5 - $54.2 $18,769 - $47,316	-873 Reduced 15.68%	4,696 $152,000
Q4 2019 Feb 06, 2020	BUY	$34.54 - $44.87 $27,597 - $35,851	799 Added 16.75%	5,569 $228,000
Q4 2019 Feb 04, 2020	SELL	$34.54 - $44.87 $3,868 - $5,025	-112 Reduced 2.29%	4,770 $208,000
Q3 2019 Nov 12, 2019	SELL	$31.84 - $50.88 $1.16 Million - $1.85 Million	-36,377 Reduced 88.17%	4,882 $174,000
Q2 2019 Aug 15, 2019	SELL	$42.0 - $59.29 $110,040 - $155,339	-2,620 Reduced 5.97%	41,259 $2.12 Million
Q1 2019 May 03, 2019	SELL	$40.82 - $62.45 $20,001 - $30,600	-490 Reduced 1.1%	43,879 $2.52 Million
Q4 2018 Feb 05, 2019	BUY	$39.11 - $75.15 $371,936 - $714,676	9,510 Added 27.28%	44,369 $1.86 Million
Q3 2018 Nov 01, 2018	SELL	$65.0 - $82.15 $1.87 Million - $2.36 Million	-28,750 Reduced 45.2%	34,859 $2.63 Million
Q2 2018 Aug 02, 2018	SELL	$27.2 - $74.35 $96,560 - $263,942	-3,550 Reduced 5.29%	63,609 $4.56 Million
Q1 2018 May 04, 2018	BUY	$24.05 - $37.5 $176,286 - $274,875	7,330 Added 12.25%	67,159 $2.01 Million
Q4 2017 Feb 01, 2018	BUY	$26.0 - $34.6 $293,800 - $390,980	11,300 Added 23.29%	59,829 $1.99 Million
Q3 2017 Oct 27, 2017	BUY	$18.0 - $32.95 $37,260 - $68,206	2,070 Added 4.46%	48,529 $1.6 Million
Q2 2017 Aug 07, 2017	BUY	N/A	46,459	46,459 $918,000

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account